Elise Wang

Elise Wang

Signal active

Partner, Head of Private Equity Capital Markets

Bio

As an Analyst on the Private Transactions team, Elise provides extensive research and analysis on individual companies operating in the healthcare industry in both the US and Europe.

Prior to joining Deerfield in 2010, Elise began her career in healthcare in 1987 as a venture capitalist and banker at PaineWebber Inc. and was an officer of PaineWebber Development Corporation, which managed nearly $1.0 billion in assets representing three PaineWebber funds and several research and development limited partnerships (RDLPs) invested in biotechnology and high technology companies. From 1996 to 2007, Elise was a Senior Research Analyst and Managing Director in healthcare primarily covering the biotechnology industry at PaineWebber Inc. (1996-2001) and Citigroup (2001-2007).

She holds an A.B. in Engineering Sciences with a specialty in Biomechanics from Harvard University and an M.B.A. from Harvard Business School.

Location

New York, New York, United States, North America

Social

Primary Organization

Deerfield

Deerfield

Founded

1994

Investment

271

Lead investment

143

Exits

128

Employees

101-250

Industry

Financial Services, Venture Capital, Impact Investing, Hedge Funds

Jobs history

1

HilleVax

Board Member

2021 - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Elise Wang is the Partner, Head of Private Equity Capital Markets at Deerfield, based in New York, New York, United States, North America. With a background in Financial Services, Elise Wang has a rich history of leadership and innovation. Elise Wang studied unknown unknown @ Harvard Business School. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

4

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Aug 13, 2018
Orchard Therapeutics Orchard Therapeutics
Series C - Orchard Therapeutics
-150.0M
Jan 07, 2021
Werewolf Therapeutics Werewolf Therapeutics
Series B - Werewolf Therapeutics
Werewolf Therapeutics Deerfield
72.0M
Sep 08, 2021
HilleVax HilleVax
Venture Round - HilleVax
HilleVax Deerfield
135.0M
Jun 05, 2024
Advanced Medicine Partners Advanced Medicine Partners
Series A - Advanced Medicine Partners
Advanced Medicine Partners Deerfield
32.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.